Early US Experience Using the Symani for Robotic‐Assisted Microvascular Surgery

BACKGROUND: Robotic-assisted microsurgery provides motion scaling, tremor filtration, and enhanced visualization, offering potential advantages for complex microsurgical tasks. Following Food and Drug Administration authorization, the Symani Surgical System was introduced into clinical practice in the United States in April 2024. This study presents the first multi-institutional US experience with Symani, evaluating feasibility, reconstructive outcomes, and technical challenges during its inaugural year of use in the United States. METHODS: All robotic-assisted procedures performed between April 2024 and April 2025 at two tertiary academic centers were retrospectively reviewed. Demographics, clinical indications, flap type, and anastomotic details were extracted. Primary outcomes were anastomotic patency and flap loss. Secondary outcomes included overall surgical complications and conversion to conventional microsurgery. RESULTS: Twenty-seven patients underwent robotic-assisted microsurgical procedures. Median age was 51 [IQR 39-63] years; 55.6% were female, and 74.1% identified as White. Indications included oncologic reconstruction (48.1%), trauma (18.5%), degenerative bony disease (14.8%), infection (11.1%), peripheral vascular disease (3.7%), and morphea (3.7%). A wide variety of flaps were performed, most commonly deep inferior epigastric perforator (DIEP) (44.4%), free vascularized fibular grafts (18.5%), and scapular flaps (14.8%). Robotic assistance was employed for 27 arterial anastomoses (84.4%), three venous anastomoses (9.4%), and two nerve coaptations (6.3%). Anastomotic configuration was predominantly end-to-end (71.9%). No flap loss occurred. One patient (3.7%) required re-exploration for pedicle kinking. Two conversions to conventional non-robotic microsurgery were required (7.4%). CONCLUSIONS: Early US multi-institutional experience demonstrates the Symani system is feasible and safe across diverse reconstructive procedures, enabling reliable microvascular anastomoses and nerve coaptations with minimal complications and no flap loss.

Authors

Institutions

Publication Details

Journal
Microsurgery
Published
2026-11-16
DOI
https://doi.org/10.1002/micr.70319
Primary Topic
Reconstructive Surgery and Microvascular Techniques
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Early US Experience Using the Symani for Robotic‐Assisted Microvascular Surgery

Arturo Jesus Rios-Diaz, Stephen J. Kovach, Jessica F. Rose, Berk Barış Özmen et al.
Microsurgery
Reconstructive Surgery and Microvascular Techniques
article

Early US Experience Using the Symani for Robotic‐Assisted Microvascular Surgery

Arturo Jesus Rios-Diaz, Stephen J. Kovach, Jessica F. Rose, Berk Barış Özmen, Sarah N. Bishop, Lawrence Scott Levin, Diwakar Phuyal, Graham S. Schwarz, Risal S. Djohan, Ines Lin
article en

Abstract

BACKGROUND: Robotic-assisted microsurgery provides motion scaling, tremor filtration, and enhanced visualization, offering potential advantages for complex microsurgical tasks. Following Food and Drug Administration authorization, the Symani Surgical System was introduced into clinical practice in the United States in April 2024. This study presents the first multi-institutional US experience with Symani, evaluating feasibility, reconstructive outcomes, and technical challenges during its inaugural year of use in the United States. METHODS: All robotic-assisted procedures performed between April 2024 and April 2025 at two tertiary academic centers were retrospectively reviewed. Demographics, clinical indications, flap type, and anastomotic details were extracted. Primary outcomes were anastomotic patency and flap loss. Secondary outcomes included overall surgical complications and conversion to conventional microsurgery. RESULTS: Twenty-seven patients underwent robotic-assisted microsurgical procedures. Median age was 51 [IQR 39-63] years; 55.6% were female, and 74.1% identified as White. Indications included oncologic reconstruction (48.1%), trauma (18.5%), degenerative bony disease (14.8%), infection (11.1%), peripheral vascular disease (3.7%), and morphea (3.7%). A wide variety of flaps were performed, most commonly deep inferior epigastric perforator (DIEP) (44.4%), free vascularized fibular grafts (18.5%), and scapular flaps (14.8%). Robotic assistance was employed for 27 arterial anastomoses (84.4%), three venous anastomoses (9.4%), and two nerve coaptations (6.3%). Anastomotic configuration was predominantly end-to-end (71.9%). No flap loss occurred. One patient (3.7%) required re-exploration for pedicle kinking. Two conversions to conventional non-robotic microsurgery were required (7.4%). CONCLUSIONS: Early US multi-institutional experience demonstrates the Symani system is feasible and safe across diverse reconstructive procedures, enabling reliable microvascular anastomoses and nerve coaptations with minimal complications and no flap loss.

MicrosurgeryVol. 46(8)
Cleveland Clinic (US), University of Pennsylvania (US)
Reconstructive Surgery and Microvascular Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon